Shop
Showing 1073–1088 of 1900 results
-
Article: Operational Risk Management (ORM): the aviation safety model can be transposed into the medical sector
€2.42 Add to cart -
Article: Opportunities and challenges in oncology and molecular testing: the Belgian strategy
€2.42 Add to cart -
Article: Optimal management of pancreatic cancer: current standards and challenges for improving care and research
€2.42 Add to cart -
Article: Optimizing patient outcomes in CML
€2.42 Add to cart -
Article: Overview of trials running in the Benelux
€2.42 Add to cart -
Article: Overview of trials running in the Benelux
€2.42 Add to cart -
Article: Overview of trials running in the Benelux
€2.42 Add to cart -
Article: Overview of trials running in the Benelux
€2.42 Add to cart -
Article: Overview of trials running in the Benelux
€2.42 Add to cart -
Article: P.01 NUP214-ABL1 mediated cell proliferation in T-ALL depends on the LCK kinase and various interacting proteins
€2.42 Add to cart -
Article: P.02 H3K27me3 erasers, novel targets in T-cell acute lymphoblastic leukaemia
€2.42 Add to cart -
Article: P.03 Extending the functional redundant cooperative miRNA tumour suppressor and oncogene network in T-ALL
€2.42 Add to cart -
Article: P.04 HDAC in Chronic Lymphocytic Leukaemia: expression profile, enzymatic activity and prognostic significance
€2.42 Add to cart -
Article: P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity
€2.42 Add to cart -
Article: P.06 Safety and efficacy of abbreviated induction with oral fludarabine (F) and cyclophosphamide (C) combined with dose-dense iv rituximab (R) in previously untreated patients with chronic lymphocytic leukaemia (CLL) aged > 65 years: results of a multicentre trial (LLC 2007 SA) on behalf of the French
€2.42 Add to cart -
Article: P.07 Interim analysis of the randomized EORTC/ LYSA/FIL Intergroup H10 trial on early PET-scan driven treatment adaptation in stage I/II Hodgkin lymphoma
€2.42 Add to cart
